PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

Riluzole and Sorafenib in patients with advanced solid tumors: a Phase I trial

Riluzole and Sorafenib in patients with advanced solid tumors: a Phase I trial
2023-04-12
(Press-News.org)

“Our phase I study determined the tolerable dose of this combination and investigated its biologic effects.” 

BUFFALO, NY- April 12, 2023 – A new research paper was published in Oncotarget's Volume 14 on April 10, 2023, entitled, “A phase I trial of riluzole and sorafenib in patients with advanced solid tumors: CTEP #8850.”

Overexpression of metabotropic glutamate receptor 1 (GRM1) has been implicated in the pathogenesis of multiple cancers. Riluzole, an inhibitor of glutamate release, showed synergistic antitumor activity in combination with the multi-kinase inhibitor sorafenib in preclinical models.

In a new phase I trial, researchers Kristen R. Spencer, Daniella E. Portal, Joseph Aisner, Mark N. Stein, Jyoti Malhotra, Weichung Shih, Nancy Chan, Ann W. Silk, Shridar Ganesan, Susan Goodin, Murugesan Gounder, Hongxia Lin, Jiadong Li, Robert Cerchio, Christina Marinaro, Suzie Chen, and Janice M. Mehnert from Rutgers University, Dana-Farber Cancer Institute, and the Perlmutter Cancer Center of NYU Langone Health identified the toxicity profile, dose-limiting toxicities, maximum tolerated dose (MTD), and pharmacokinetic and pharmacodynamic properties of riluzole combined with sorafenib in patients with advanced cancers.

“Riluzole functions as an inhibitor of GRM1 signaling through antagonism of glutamate release, and sorafenib is a multi-kinase inhibitor targeting both the MAPK and PI3K/AKT pathways through the inhibition of RAF1, ARAF and, to a lesser extent BRAF, as well as a set of tyrosine kinases including VEGFR. Our phase I study determined the tolerable dose of this combination and investigated its biologic effects.”

Patients with refractory solid tumors were enrolled utilizing a 3+3 dose-escalation design. Riluzole was given at 100 mg PO BID in combination with sorafenib, beginning at 200 mg PO daily and escalating in 200 mg increments per level in 28-day cycles. Restaging evaluations were performed every 2 cycles. In total, 35 patients were enrolled over 4 dose levels. 

The MTD was declared at dose level 3 (riluzole: 100 mg PO BID; sorafenib: 400 mg AM/200 mg PM). Pharmacokinetic analyses did not reveal definitive evidence of drug-drug interactions. Consistent decreases in phospho-forms of ERK and AKT in tumor tissue analyses with accompanying decrease in GRM1 expression and increase in pro-apoptotic BIM suggest target engagement by the combination. Best responses included a partial response in 1 (2.9%) patient with pancreatic acinar cell carcinoma with a KANK4-RAF1 fusion, and stable disease in 11 (36%) patients.

“Combination therapy with riluzole and sorafenib was safe and tolerable in patients with advanced solid tumors. The partial response in a patient with a RAF1 fusion suggests that further exploration in a genomically selected cohort may be warranted.”

 

Read the full research paper: DOI: https://doi.org/10.18632/oncotarget.28403 

Correspondence to: Janice M. Mehnert

Email: Janice.Mehnert@nyulangone.org 

Keywords: GRM1, riluzole, sorafenib, phase I, clinical trial

 

About Oncotarget: Oncotarget (a primarily oncology-focused, peer-reviewed, open access journal) aims to maximize research impact through insightful peer-review; eliminate borders between specialties by linking different fields of oncology, cancer research and biomedical sciences; and foster application of basic and clinical science.

To learn more about Oncotarget, visit Oncotarget.com and connect with us on social media:

Twitter  Facebook  YouTube  Instagram  LinkedIn  Pinterest  LabTube Soundcloud  

Click here to subscribe to Oncotarget publication updates.

For media inquiries, please contact: media@impactjournals.com.

 

Oncotarget Journal Office

6666 East Quaker Str., Suite 1A

Orchard Park, NY 14127

Phone: 1-800-922-0957 (option 2)

###

END


[Attachments] See images for this press release:
Riluzole and Sorafenib in patients with advanced solid tumors: a Phase I trial Riluzole and Sorafenib in patients with advanced solid tumors: a Phase I trial 2

ELSE PRESS RELEASES FROM THIS DATE:

COVID-19 increased weekday screentime for children: study

2023-04-12
The COVID-19 pandemic led to increased weekday screentime for school-aged children says a new study involving the University of Ottawa published in JAMA Pediatrics. Researchers examined the change in children’s screen time from prior to the pandemic to three separate pandemic waves between 2020 and 2021. Researchers found a boost of up to 1.35 hours per day during the weekdays compared to prior to the pandemic, particularly with school closures at the onset of the pandemic. While the weekend time was on par with pre-pandemic levels, ...

In search of a better semiconductor chip

In search of a better semiconductor chip
2023-04-12
A University of Texas at Arlington materials science and engineering researcher is working on a project to determine when failure happens in electronic device circuits. The research ultimately will help manufacturers design better semiconductor chips. Choong-Un Kim, professor in the Department of Materials Science and Engineering, was awarded a $285,0000 grant from the Semiconductor Research Corporation (SRC) for the project “Enabling Electromigration Solver for Solder Joint With Various Packaging Structures and Alloys.” This is the latest in a series of grants he has received from SRC that aims to answer the demand for improved device reliability. The SRC ...

All-optical quantum state sharing via continuous variable system

All-optical quantum state sharing via continuous variable system
2023-04-12
Quantum information is a powerful technology for increasing the amount of information that can be processed and communicated securely. Using quantum entanglement to securely distribute a secret quantum state among multiple parties is known as “quantum state sharing.” An important protocol in quantum networks and cryptography, quantum state sharing works like this (in simple terms): a secret quantum state is divided into n shares and given to n players. The secret state can only be reconstructed ...

Father’s alcohol consumption before conception linked to brain and facial defects in offspring

2023-04-12
According to the U.S. Surgeon General, women should not drink alcoholic beverages during pregnancy because of the risk of birth defects in their unborn child. Now, research at Texas A&M University demonstrates that a father’s alcohol consumption before conception also links to growth defects that affect the development of his offspring’s brain, skull and face.  Research investigating fetal alcohol syndrome (FAS) exclusively examines maternal alcohol exposure. However, because men drink more and are more likely to binge drink than women, Dr. Michael Golding, an associate ...

New technique allows researchers to dig into molecular causes of pediatric bipolar disorder

New technique allows researchers to dig into molecular causes of pediatric bipolar disorder
2023-04-12
It’s extremely difficult to study the biological basis of psychiatric disorders, in part because researchers can’t easily collect brain cells from living people to study in the laboratory. Now, University of Utah Health scientists have developed a way around that. The researchers grew three-dimensional structures, called “organoids”, derived from blood cells donated by a patient with pediatric bipolar disorder and by several family members. The approach identified significant molecular changes linked to the psychiatric condition. The results, reported in Molecular Psychiatry, suggest that structural changes in the ...

COVID-19 pandemic will disrupt cancer reporting for years to come

2023-04-12
Key takeaways: American College of Surgeons research published in JAMA Surgery reveals the complexities and variations that occurred in cancer reporting in the National Cancer Database (NCDB) because of the pandemic. The number of reported cancer cases in NCDB declined by 14.4% compared with prior years, representing more than 200,000 cancer cases that were not diagnosed and/or treated at accredited facilities. Research offers guidance to centers across the country on how to interpret data from 2020 and onwards. CHICAGO: New research from the American College of Surgeons (ACS) outlines significant ways that the COVID-19 pandemic destabilized usual patterns of cancer care as reported ...

Is the language you speak tied to outcome after stroke?

2023-04-12
MINNEAPOLIS – Studies have shown that Mexican Americans have worse outcomes after a stroke than non-Hispanic white Americans. A new study looks at whether the language Mexican American people speak is linked to how well they recover after a stroke. The study is published in the April 12, 2023, online issue of Neurology®, the medical journal of the American Academy of Neurology. “Our study found that Mexican American people who spoke only Spanish had worse neurologic outcomes three months after having a stroke than Mexican American people who spoke only English or were bilingual,” said study author ...

Archaeological sites at risk from coastal erosion on the Cyrenaican coast, Libya

Archaeological sites at risk from coastal erosion on the Cyrenaican coast, Libya
2023-04-12
Archaeological sites along the Libyan shoreline are at risk of being damaged or lost due to increasing coastal erosion, according to a study published April 12, 2023 in the open-access journal PLOS ONE by Kieran Westley and Julia Nikolaus of Ulster University, UK and colleagues. The Cyrenaican coast of Eastern Libya, stretching from the Gulf of Sirte to the current Egypt-Libya border, has a long history of human occupation back to the Palaeolithic era, and it therefore hosts numerous important and often ...

Poor family cohesion is associated with long-term psychological impacts in bereaved teenagers

Poor family cohesion is associated with long-term psychological impacts in bereaved teenagers
2023-04-12
The death of a parent can affect the health and well-being of children and adolescents, including higher risk of depression. A study published in PLOS ONE by Dröfn Birgisdóttir at Lund University, Lund, Sweden and colleagues suggests poor family cohesion is associated with long-term psychological symptoms among bereaved youth. Parentally bereaved children are at increased risk for mental illness including depression, anxiety, suicide attempts, and self-injurious behaviors. However, the relationship ...

The stripes of the Lesser Pacific Striped Octopus are as unique as our own fingerprints, enabling scientists to track individuals as they grow

The stripes of the Lesser Pacific Striped Octopus are as unique as our own fingerprints, enabling scientists to track individuals as they grow
2023-04-12
Article URL:  https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0265292 Article Title: Individually unique, fixed stripe configurations of Octopus chierchiae allow for photoidentification in long-term studies Author Countries: USA Funding: The authors received no specific funding for this work. END ...

LAST 30 PRESS RELEASES:

Kidney cancer study finds belzutifan plus pembrolizumab post-surgery helps patients at high risk for relapse stay cancer-free longer

Alkali cation effects in electrochemical carbon dioxide reduction

Test platforms for charging wireless cars now fit on a bench

$3 million NIH grant funds national study of Medicare Advantage’s benefit expansion into social supports

Amplified Sciences achieves CAP accreditation for cutting-edge diagnostic lab

Fred Hutch announces 12 recipients of the annual Harold M. Weintraub Graduate Student Award

Native forest litter helps rebuild soil life in post-mining landscapes

Mountain soils in arid regions may emit more greenhouse gas as climate shifts, new study finds

Pairing biochar with other soil amendments could unlock stronger gains in soil health

Why do we get a skip in our step when we’re happy? Thank dopamine

UC Irvine scientists uncover cellular mechanism behind muscle repair

Platform to map living brain noninvasively takes next big step

Stress-testing the Cascadia Subduction Zone reveals variability that could impact how earthquakes spread

We may be underestimating the true carbon cost of northern wildfires

Blood test predicts which bladder cancer patients may safely skip surgery

Kennesaw State's Vijay Anand honored as National Academy of Inventors Senior Member

Recovery from whaling reveals the role of age in Humpback reproduction 

Can the canny tick help prevent disease like MS and cancer?

Newcomer children show lower rates of emergency department use for non‑urgent conditions, study finds

Cognitive and neuropsychiatric function in former American football players

From trash to climate tech: rubber gloves find new life as carbon capturers materials

A step towards needed treatments for hantaviruses in new molecular map

Boys are more motivated, while girls are more compassionate?

Study identifies opposing roles for IL6 and IL6R in long-term mortality

AI accurately spots medical disorder from privacy-conscious hand images

Transient Pauli blocking for broadband ultrafast optical switching

Political polarization can spur CO2 emissions, stymie climate action

Researchers develop new strategy for improving inverted perovskite solar cells

Yes! The role of YAP and CTGF as potential therapeutic targets for preventing severe liver disease

Pancreatic cancer may begin hiding from the immune system earlier than we thought

[Press-News.org] Riluzole and Sorafenib in patients with advanced solid tumors: a Phase I trial